EMPLOYMENT AGREEMENT for David FractorEmployment Agreement • November 9th, 2015 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is made between ImmunoCellular Therapeutics, Ltd. (the “Company”) and David Fractor (“Executive”) (collectively, the “Parties”), effective as of the date signed by all Parties (the “Effective Date”).
SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 9th, 2015 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations
This SECOND Amendment (the “Second Amendment”) to the Exclusive License Agreement (JHU Agreement A20530) dated February 16, 2012 and First Amendment (JHU Agreement A24634) dated September 24, 2013 (the Exclusive License Agreement and the First Amendment referred to herein as the “Agreement”), is entered into as of August 7, 2015 (“Amendment Effective Date”), by and among ImmunoCellular Therapeutics Ltd., a Delaware limited liability company having an address at 23622 Calabasas Road, Suite 300, Calabasas, CA 91302 (“COMPANY”) and Johns Hopkins University (“JHU”), having offices at 3400 N. Charles Street, Baltimore, MD 21218-2695.
